(Press-News.org) LONDON, ON – Recently published in The Journal of Translational Medicine, a team at Lawson Health Research Institute has discovered unique patterns of blood plasma proteins in patients with long COVID that could reveal potential drug targets to improve patient outcomes.
Currently, 10-20 per cent of people with a confirmed case of COVID-19 will be diagnosed with long COVID.
“Those patients experience a wide variety of symptoms, which may include fatigue, brain fog and difficulty breathing,” says Dr. Douglas Fraser, Lawson Scientist and Critical Care Physician at London Health Sciences Centre (LHSC). “Their quality of life can be significantly altered, so anything that we can do to learn about this disorder and identify potential treatment targets is very important.”
Called “the plasma proteome,” the proteins being studied are found in blood plasma and are released by cells that often play an important role in the body’s immune response to viruses. The research team is studying how those proteins adapt and change in long COVID.
“Trying to understand this mechanism is quite important because it provides further insight into how patients are affected,” says Dr. Michael Nicholson, Associate Scientist at Lawson and Respirologist at St. Joseph’s Health Care London (St. Joseph’s). “This paper sheds further light onto several possible mechanisms that may provide insight into why some patients have certain symptoms.”
As part of the study, blood plasma samples were collected from long COVID outpatients through the Post-Acute COVID-19 Program at St. Joseph’s and analyzed in comparison to acutely ill COVID-19 inpatients at London Health Sciences Centre (LHSC), as well as compared to a group of healthy volunteers.
“We used novel technologies for this study, allowing us to analyze more than 3,000 proteins in each patients’ blood plasma sample,” explains Cristiana Iosef, Research Analyst at Children’s Health Research Institute (CHRI), a program of Lawson. “We used novel bioinformatic pipeline, which uses artificial intelligence (AI) technology, to then analyze the proteins to determine the specific changes that occur in long COVID.”
By using advanced technology the researchers were able to determine unique signaling patterns from the blood proteins. The team discovered that people with long COVID have prolonged inflammation associated with changes in their immune cells and blood vessels. These changes may lead to problems in specific organs, like the brain and the heart.
Dr. Fraser, who is also a Professor at Western University, adds that the proteins discovered could serve as a future diagnostic test, as well as reveal potential drug targets. The team is now examining potential new drug therapies with the hopes of improving outcomes for these patients.
“When we identify these signaling patterns within the blood plasma, we can then take the information and screen drug databases to better understand which drugs would be best to target the changes we identified in long COVID patients,” says Dr. Fraser. “With this understanding, the identified drugs may be used in future long COVID clinical trials.”
This research, which used multiple state-of the-art technologies, was enabled by existing expertise and infrastructure through CHRI.
END
New study suggests blood plasma proteins hold answers to better understanding long COVID
2023-07-07
ELSE PRESS RELEASES FROM THIS DATE:
Ticks may be able to spread chronic wasting disease between Wisconsin deer
2023-07-07
Madison — A new study from researchers at the University of Wisconsin–Madison finds that ticks can harbor transmissible amounts of the protein particle that causes Chronic Wasting Disease (CWD), implicating the parasites as possible agents in the disease’s spread between deer in Wisconsin. Her findings were published in the journal Nature.
CWD is caused by a pathogenic agent called a prion, which can pass from deer-to-deer through contact with things like prion-contaminated soil and infected ...
Doom-and-gloom climate news may scare but also encourage audiences
2023-07-07
UNIVERSITY PARK, Pa. — A team of Penn State researchers investigated how seeing frightening news about climate change day after day may shape the way people feel about the phenomenon and how willing they are to take action to address it.
Christofer Skurka, Jessica Myrick and graduate student Yin Yang found that seeing bad news about climate change can make people more afraid over time, but it also may encourage audiences to think about what society can do to address the problem. They published the results of two separate studies in an article titled “Fanning the flames or burning out? Testing competing hypotheses ...
Name of Portuguese astrophysicist shines in the night sky
2023-07-07
The International Astronomical Union (IAU) has named an asteroid after Pedro Machado, astrophysicist at Institute of Astrophysics and Space Sciences (IA), at the Faculty of Sciences of the University of Lisbon (Portugal). Along with the nomination of Pedro Machado, there were over a hundred other nominations of asteroids and other small bodies.
It is almost three kilometers in diameter and takes four and a half years to complete its orbit around the sun. We’re talking about 2001 QL160, or rather the asteroid 32599 Pedromachado. Pedro Machado has been honored by the Work group for the Nomenclature of Small Bodies (WGSBN 2) of the International Astronomical ...
Charles 'Chipper' Griffith named dean of UK College of Medicine
2023-07-07
LEXINGTON, Ky. (July 6, 2023) — Charles “Chipper” Griffith III, M.D., has been named dean of the University of Kentucky College of Medicine.
Pending approval from the Board of Trustees, Griffith will begin his appointment July 15, 2023. He has served as acting dean of the college since July 2021.
Through the years, he has played an instrumental role in the health and well-being of Kentuckians, and in the academic success of thousands of students.
“Dr. Griffith understands Kentucky needs the UK College of Medicine,” said Provost Robert ...
Updating pulse oximeters
2023-07-07
Updating pulse oximeters
A portable device used to detect blood oxygen levels revolutionized the medical field 50 years ago and is now receiving essential updates
Efforts to improve the accuracy of pulse oximetry readings for diverse groups of patients and in multiple settings are underway. Joel Moss, M.D., Ph.D., a senior investigator in NHLBI’s Laboratory of Translational Research, and Bennett Yang, a postbaccalaureate fellow in Dr. Moss’s lab, describe this process and the future of pulse oximetry research.
Q: Why are portable pulse ...
July issues of American Psychiatric Association journals cover advances in social determinants of mental health, youth mental health screening, AI in psychotherapy and more
2023-07-07
The latest issues of three of the American Psychiatric Association’s journals, The American Journal of Psychiatry, Psychiatric Services and The American Journal of Psychotherapy are now available online.
The July issue of The American Journal of Psychiatry features articles on social determinants of health relevant to racial and ethnic disparities as well as postmortem molecular studies. Highlights include:
Recent Advances on Social Determinants of Mental Health: Looking Fast Forward.
Differences in Social Determinants of Health Underlie Racial/Ethnic Disparities in Psychological Health and Well-Being: Study of 11,143 Older Adults.
The Nature ...
Breakthrough identifies new state of topological quantum matter
2023-07-07
ITHACA, N.Y. -- Cornell scientists have revealed a new phase of matter in candidate topological superconductors that could have significant consequences for condensed matter physics and for the field of quantum computing and spintronics.
Researchers at the Macroscopic Quantum Matter Group at Cornell have discovered and visualized a crystalline yet superconducting state in a new and unusual superconductor, Uranium Ditelluride (UTe2), using one of the world’s most powerful millikelvin Scanned Josephson Tunnelling Microscopes (SJTM). This “spin-triplet electron-pair crystal” is a previously unknown state of topological quantum matter.
The findings, ...
Fecal transplants show promise in improving melanoma treatment
2023-07-07
LONDON, ON – In a world-first clinical trial published in the journal Nature Medicine, a multi-centre study from Lawson Health Research Institute, the Centre hospitalier de l’Université de Montréal (CHUM) and the Jewish General Hospital (JGH) has found fecal microbiota transplants (FMT) from healthy donors are safe and show promise in improving response to immunotherapy in patients with advanced melanoma.
Immunotherapy drugs stimulate a person’s immune system to attack and destroy cancer. While they can significantly improve survival outcomes in those with melanoma, they are only ...
Privacy-preserving collaborative data collection and analysis with many missing values
2023-07-07
To control pandemics like the novel coronavirus infection (COVID-19), data such as the age, gender, family composition, and medical history of infected individuals are required. While patients themselves may provide this information to medical institutions, these details are highly confidential. If the data is properly handled for privacy protection, it can be shared with researchers worldwide without identifying the infected individual, which can help clarify the state of the pandemic and more accurately predict its progression.
There ...
Hexagonal MBene: A promising platform for the electrocatalytic nitrogen reduction reaction
2023-07-07
They published their work on July. 6 in Energy Material Advances.
"In 2017, we reported a new family of 2D transition metal borides as analogues to MXenes and coined a catchy name for them, MBenes," said paper author Zhimei Sun, professor of the School of Materials Science and Engineering at Beihang University. "Up till now, MBenes have been widely studied as catalysts or substrates of various reactions, including HER, ORR/OER, NRR and CO2RR. Notably, the exploration of electrocatalytic performance for MBenes mainly focuses on those with orthorhombic structures, while there are few studies on applying ...